Living Health Technology Assessment: Issues, Challenges and Opportunities
Author:
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Link
https://link.springer.com/content/pdf/10.1007/s40273-022-01229-4.pdf
Reference39 articles.
1. Kirwin E, Round J, Bond K, McCabe C. A conceptual framework for life-cycle health technology assessment. Value Health. 2022;25(7):1116–23. https://doi.org/10.1016/j.jval.2021.11.1373.
2. Gopalakrishnan S, Ganeshkumar P. Systematic reviews and meta-analysis: understanding the best evidence in primary healthcare. J Fam Med Prim Care. 2013;2(1):9. https://doi.org/10.4103/2249-4863.109934.
3. Moher D, Liberati A, Tetzlaff J, Altman D, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9. https://doi.org/10.1371/journal.pmed.1000097.
4. Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1–11. https://doi.org/10.1186/s13643-021-01626-4.
5. Andersen M, Gulen S, Fonnes S, Andresen K, Rosenberg J. Half of Cochrane reviews were published more than 2 years after the protocol. J Clin Epidemiol. 2020;124:85–93. https://doi.org/10.1016/j.jclinepi.2020.05.011.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Artificial intelligence applied in human health technology assessment: a scoping review protocol;JBI Evidence Synthesis;2024-09-03
2. Consumer engagement in living evidence “a beautiful opportunity”: International qualitative study with patients and methodologists;Clinical and Public Health Guidelines;2024-09
3. Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis;Value in Health;2024-06
4. A Prototype Software Framework for Transferable Computational Health Economic Models and Its Early Application in Youth Mental Health;PharmacoEconomics;2024-05-20
5. Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review;PharmacoEconomics;2024-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3